Clinical Course in HCV 2012 — Strategies for Overcoming Practice-Based Barriers to Care in Hepatitis C: New Models of Care in HCV
As part of the Clinical Course in HCV 2012 planned series, an educational collaboration between MedscapeCME and the AGA Institute, this activity provides clinicians who manage viral hepatitis with timely, comprehensive medical education in a variety of learning formats.
This activity will review novel approaches to overcome practice-based barriers to HCV treatment and prevention and increase the confidence of nonspecialists in their ability to treat patients and manage chronic HCV infection.
*Requires free registration.
http://www.gastro.org/education-meetings/online-education/clinical-course-in-hcv-2012-strategies-for-overcoming-practicebased-barriers-to-care-in-hepatitis-c-new-models-of-care-in-hcv
This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment